Development Stage: Already performed product demonstration

Project information:

Chematria makes software that helps pharmaceutical companies determine which molecules can become medicines. With Chematria’s proprietary approach to molecular docking simulations, pharmaceutical researchers can confidently predict potent molecules for novel biological targets, thereby enabling faster drug development for a fraction of the price of wet-lab experiments. Chematria has already performed product demonstrations and are looking for partnerships with facilities to further carry out wet-lab validation.